Consistent with the in vitro observations, silencing USP22 led to a dramatic decrease in tumor volume and weight compared with the control cells (Figure 4A–4C), and also enhanced chemosensitivity to 5-Fu in vivo (Figure 4D–4F). The gene discussed is USP22; the disease is neoplasm.